JP2018524320A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018524320A5 JP2018524320A5 JP2017566028A JP2017566028A JP2018524320A5 JP 2018524320 A5 JP2018524320 A5 JP 2018524320A5 JP 2017566028 A JP2017566028 A JP 2017566028A JP 2017566028 A JP2017566028 A JP 2017566028A JP 2018524320 A5 JP2018524320 A5 JP 2018524320A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- crystal
- cyclic amide
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562182142P | 2015-06-19 | 2015-06-19 | |
| US62/182,142 | 2015-06-19 | ||
| PCT/US2016/038340 WO2016205785A1 (en) | 2015-06-19 | 2016-06-20 | Pharmaceutical composition of carboplatin based co-crystals and use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018524320A JP2018524320A (ja) | 2018-08-30 |
| JP2018524320A5 true JP2018524320A5 (2) | 2019-07-11 |
| JP6768716B2 JP6768716B2 (ja) | 2020-10-14 |
Family
ID=57546414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017566028A Expired - Fee Related JP6768716B2 (ja) | 2015-06-19 | 2016-06-20 | カルボプラチンベースの共結晶の医薬組成物及びその用途 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10421770B2 (2) |
| EP (1) | EP3297636B1 (2) |
| JP (1) | JP6768716B2 (2) |
| KR (1) | KR20180018800A (2) |
| CN (1) | CN107847508B (2) |
| AU (1) | AU2016279099B2 (2) |
| BR (1) | BR112017027285A2 (2) |
| CA (1) | CA2988992A1 (2) |
| WO (1) | WO2016205785A1 (2) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2016265922B2 (en) * | 2015-05-18 | 2021-05-20 | Syn-Nat Products Enterprise LLC | A pharmaceutical co-crystal and use thereof |
| BR112017027277A2 (pt) | 2015-06-19 | 2018-09-04 | Syn Nat Products Entpr Llc | ?método para o tratamento ou prevenção de uma doença e métodos para matar uma célula? |
| BR112017027285A2 (pt) | 2015-06-19 | 2018-09-11 | Syn Nat Products Entpr Llc | ?cocristal, composição farmacêutica e método para o tratamento de uma doença? |
| US10428099B2 (en) | 2015-06-25 | 2019-10-01 | Syn-Nat Products Enterprise LLC | Pharmaceutical co-crystal composition and use thereof |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5922689A (en) | 1995-09-11 | 1999-07-13 | Unitech Pharmaceuticals, Inc. | Cisplatin analogs for cancer treatment |
| US6297245B1 (en) | 1998-08-04 | 2001-10-02 | Unitech Pharmaceuticals | Cisplatin and folic acid administered to treat breast cancer |
| KR100317473B1 (ko) | 1999-05-11 | 2001-12-22 | 이계호 | 신규의 백금(ｉｖ)착제 및 그 제조방법 |
| CN1121380C (zh) | 2000-03-03 | 2003-09-17 | 北京兴大豪斯科技有限公司 | 一种抗肿瘤的双二羧酸二氨络铂衍生物及其药物组合物 |
| AUPQ641100A0 (en) | 2000-03-23 | 2000-04-15 | Australia Nuclear Science & Technology Organisation | Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents |
| ATE431352T1 (de) * | 2001-11-30 | 2009-05-15 | Jingzun Wang | Supermolekulare carboplatinderivate, deren herstellung und pharmazeutische zusammensetzungen,die diese als wirkstoffe enthalten, sowie anwendungen der zusammensetzungen |
| US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| AU2003250483A1 (en) | 2002-08-19 | 2004-03-11 | Pfizer Products Inc. | Combination therapy for hyperproliferative diseases |
| JP2007524596A (ja) * | 2003-02-28 | 2007-08-30 | トランスフォーム・ファーマシューティカルズ・インコーポレイテッド | 共結晶医薬組成物 |
| WO2004099224A1 (de) | 2003-05-05 | 2004-11-18 | Universität Regensburg | Carboplatin-artige platin (ii)- komplexe |
| AU2004270655B2 (en) | 2003-08-13 | 2011-03-24 | University Of South Florida | Methods for inhibiting tumor cell proliferation |
| US9682043B2 (en) * | 2003-12-09 | 2017-06-20 | Medcrystalforms, Llc | Method of preparation of mixed phase co-crystals with active agents |
| CN101146532B (zh) * | 2005-01-21 | 2012-05-09 | 阿斯泰克斯治疗有限公司 | 药物化合物 |
| CN100500219C (zh) * | 2005-04-06 | 2009-06-17 | 山东蓝金生物工程有限公司 | 一种含铂类化合物的抗实体肿瘤药物组合物 |
| US7956208B2 (en) | 2006-01-30 | 2011-06-07 | Platco Technologies (Proprietary) Limited | Preparation of platinum (II) complexes |
| DK2049109T3 (en) | 2006-08-02 | 2016-01-11 | Sunesis Pharmaceuticals Inc | Combined use of (+) - 1,4-dihydro-7 - [(3S, 4S) -3-methoxy-4- (methylamino) -1-pyrrolidinyl] -4-oxo-1- (2-thiazolyl) -1,8-naphthyridine-3-carboxylic acid and cytarabine (Ara-C) for the treatment of leukemia |
| CN101679372A (zh) * | 2007-03-02 | 2010-03-24 | 诺瓦提斯公司 | Raf激酶抑制剂的固体形式 |
| US20090181068A1 (en) * | 2008-01-14 | 2009-07-16 | Dunn Richard L | Low Viscosity Liquid Polymeric Delivery System |
| KR100957125B1 (ko) * | 2008-01-14 | 2010-05-11 | 한국과학기술원 | 생체 고분자와 난용성 물질의 접합체 및 그의 제조방법 |
| KR20110063537A (ko) | 2008-09-15 | 2011-06-10 | 카시나 라일라 이노바 파마슈티칼스 프라이빗 리미티드 | 전이성 악성 흑색종 및 기타 암에 대한 항암 약물 및 이와 관련한 용도 |
| CZ302618B6 (cs) | 2009-09-10 | 2011-08-03 | Univerzita Palackého | Cyklobutan-1,1-dikarboxylátokomplexy platiny s deriváty N6-benzyladeninu, zpusoby jejich prípravy a použití techto komplexu jako léciv v protinádorové terapii |
| US20110287110A1 (en) | 2010-04-23 | 2011-11-24 | Mark Wesley Dewhirst | Combination cancer treatment |
| JP5179628B2 (ja) | 2011-07-15 | 2013-04-10 | ユニーテック株式会社 | ４価白金錯体及びそれを含む医薬組成物 |
| US9220705B2 (en) | 2013-03-07 | 2015-12-29 | James David Hoeschele | Method of treating colorectal cancer |
| JP6408569B2 (ja) * | 2013-10-17 | 2018-10-17 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | Ｄｎａ−ｐｋ阻害剤としての（ｓ）−ｎ−メチル−８−（１−（（２’−メチル−［４，５’−ビピリミジン］−６−イル）アミノ）プロパン−２−イル）キノリン−４−カルボキサミドおよびその重水素化誘導体の共結晶 |
| CN104122280B (zh) * | 2014-08-13 | 2017-03-22 | 北京默加农生物技术发展有限公司 | 一种以双环铂为有效成分的药物的检测方法 |
| CN104127402B (zh) | 2014-08-15 | 2019-08-30 | 北京默加农生物技术发展有限公司 | 双环铂在制备抗病毒药物和抗菌药物中的应用 |
| CN104693245A (zh) * | 2015-03-13 | 2015-06-10 | 卓越同达医药科技开发（苏州）有限公司 | 超分子抗癌药物双环铂的制备方法 |
| EP3280408B1 (en) | 2015-04-10 | 2019-10-23 | Syn-Nat Products Enterprise LLC | Process for the preparation of dicycloplatin |
| US20180085377A1 (en) | 2015-04-22 | 2018-03-29 | Syn-Nat Products Enterprise LLC | Co-crystal composition and its pharmaceutical use |
| AU2016265922B2 (en) | 2015-05-18 | 2021-05-20 | Syn-Nat Products Enterprise LLC | A pharmaceutical co-crystal and use thereof |
| BR112017027285A2 (pt) | 2015-06-19 | 2018-09-11 | Syn Nat Products Entpr Llc | ?cocristal, composição farmacêutica e método para o tratamento de uma doença? |
| BR112017027277A2 (pt) | 2015-06-19 | 2018-09-04 | Syn Nat Products Entpr Llc | ?método para o tratamento ou prevenção de uma doença e métodos para matar uma célula? |
| US10428099B2 (en) | 2015-06-25 | 2019-10-01 | Syn-Nat Products Enterprise LLC | Pharmaceutical co-crystal composition and use thereof |
-
2016
- 2016-06-20 BR BR112017027285A patent/BR112017027285A2/pt not_active Application Discontinuation
- 2016-06-20 EP EP16812609.2A patent/EP3297636B1/en not_active Not-in-force
- 2016-06-20 KR KR1020187001613A patent/KR20180018800A/ko not_active Ceased
- 2016-06-20 CA CA2988992A patent/CA2988992A1/en not_active Abandoned
- 2016-06-20 CN CN201680035450.1A patent/CN107847508B/zh active Active
- 2016-06-20 JP JP2017566028A patent/JP6768716B2/ja not_active Expired - Fee Related
- 2016-06-20 WO PCT/US2016/038340 patent/WO2016205785A1/en not_active Ceased
- 2016-06-20 US US15/736,178 patent/US10421770B2/en active Active
- 2016-06-20 AU AU2016279099A patent/AU2016279099B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018520147A5 (2) | ||
| ES2958828T3 (es) | Derivados de piridina y su uso para tratar una infección por VIH | |
| JP6606692B2 (ja) | （２Ｒ，５Ｓ，１３ＡＲ）−８−ヒドロキシ−７，９−ジオキソ−Ｎ−（２，４，６−トリフルオロベンジル）−２，３，４，５，７，９，１３，１３Ａ−オクタヒドロ−２，５−メタノピリド［１’，２’：４，５］ピラジノ［２，１−ｂ］［１，３］オキサゼピン−１０−カルボキサミドの結晶形 | |
| JP2013056886A5 (2) | ||
| AU2018203175B2 (en) | Sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate | |
| JP2021165280A (ja) | Ｎ４−ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 | |
| JP2016121196A5 (2) | ||
| JP2020532532A5 (2) | ||
| JP2018524320A5 (2) | ||
| JP2016537346A5 (2) | ||
| JP2020503010A5 (2) | ||
| JP2014521688A5 (2) | ||
| JP2014503525A5 (2) | ||
| JP2018521969A5 (2) | ||
| JP2018504378A5 (2) | ||
| JP2017536344A5 (2) | ||
| BR112013002375B1 (pt) | Composto, processo de preparação do mesmo, composição farmacêutica, e, usos de um composto | |
| JP2018504379A5 (2) | ||
| JP2016529324A5 (2) | ||
| JP2018522866A5 (2) | ||
| JP2016508150A (ja) | ウイルス感染症を処置するための治療用化合物 | |
| JP2015517555A5 (2) | ||
| JP2020507589A5 (2) | ||
| JP2018515563A5 (2) | ||
| JP2012519691A5 (2) |